Treatable traits in bronchiectasis
- PMID: 30190263
- DOI: 10.1183/13993003.01269-2018
Treatable traits in bronchiectasis
Conflict of interest statement
Conflict of interest: J.D. Chalmers reports grants for COPD research and personal fees from GlaxoSmithKline, Boehringer Ingelheim and Pfizer, grants for COPD research from AstraZeneca, grants for bronchiectasis research and personal fees from Bayer Healthcare and Grifols, and personal fees for consultancy from Napp, outside the submitted work.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources